pindolol has been researched along with Cardiomyopathies in 8 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amour, J | 1 |
| Loyer, X | 1 |
| Michelet, P | 1 |
| Birenbaum, A | 1 |
| Riou, B | 1 |
| Heymes, C | 1 |
| Lübbecke, F | 1 |
| Kobayashi, A | 2 |
| Nishiyama, T | 1 |
| Ikegaya, T | 1 |
| Kaneko, M | 1 |
| Yamazaki, N | 2 |
| Lossnitzer, K | 1 |
| Konrad, A | 1 |
| Heine, HW | 1 |
| Ziegler, E | 1 |
| Stauch, M | 1 |
| Pernot, C | 1 |
| Ponsonnaille, J | 1 |
| Pailloncy, M | 1 |
| Goujon, B | 1 |
| Marcheix, JC | 1 |
| Gras, H | 1 |
| Tawarahara, K | 1 |
| Kurata, C | 1 |
| Taguchi, T | 1 |
| Pelá, G | 1 |
| Missale, C | 1 |
| Raddino, R | 1 |
| Condorelli, E | 1 |
| Spano, PF | 1 |
| Visioli, O | 1 |
8 other studies available for pindolol and Cardiomyopathies
| Article | Year |
|---|---|
Preservation of the positive lusitropic effect of beta-adrenoceptors stimulation in diabetic cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiomyopathies; Colforsin; Diabete | 2008 |
Myocardial alterations in chronic experimental renal failure.
Topics: Animals; Atrial Function, Left; Atropine; Carbachol; Cardiomyopathies; Dobutamine; Kidney Failure, C | 1994 |
Verapamil induced reduction of the myocardial beta-adrenoceptor density in BIO 14.6 cardiomyopathic Syrian hamsters.
Topics: Animals; Binding, Competitive; Calcium Channels; Cardiomyopathies; Cricetinae; Disease Models, Anima | 1993 |
[Proceedings: Prevention of myocardial degeneration in a disease model of hereditary cardiomyopathy].
Topics: Animals; Calcium; Cardiomegaly; Cardiomyopathies; Cricetinae; Disease Models, Animal; Heart; Myocard | 1975 |
[Myocardiopathy of Friedreich's disease. Apropos of a series of 17 observations].
Topics: Adolescent; Adult; Cardiomegaly; Cardiomyopathies; Child; Child, Preschool; Echocardiography; Electr | 1979 |
[Congestive-type primary myocardiopathies: treatment with beta-blocking agents].
Topics: Adult; Cardiomyopathies; Heart Failure; Humans; Middle Aged; Pindolol; Propranolol | 1978 |
Augmentation of beta adrenergic receptors in cardiomyopathic hamsters (BIO 14.6) with heart failure.
Topics: Animals; Autoradiography; Cardiomyopathies; Cricetinae; Disease Models, Animal; Iodocyanopindolol; M | 1992 |
Beta 1- and beta 2-receptors are differentially desensitized in an experimental model of heart failure.
Topics: Adenylyl Cyclases; Animals; Autoradiography; Cardiac Output, Low; Cardiomegaly; Cardiomyopathies; Fe | 1990 |